With some 12 years as CEO under his belt, Bavarian Nordic’s Paul Chaplin is telegraphing his exit from the Denmark-based ...
Since the start of the millennium, podcasts have gone from nonexistent to numbering in the millions, and Edison Research ...
As it ramps up its rollout of the first twice-yearly HIV pre-exposure prophylaxis (PrEP) medicine, Gilead Sciences is tapping into a beloved early-aughts track to familiarize consumers with Yeztugo.
Following an extensive Middle East military build-up by the U.S. in recent weeks, the U.S. and Israel on Feb. 28 launched attacks across Iran. In response, Iran launched retaliatory attacks on Israel, ...
Ahead of a rescheduled meeting of the Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices (ACIP), Department of Health and Human Services (HHS) Secretary | ...
Ascendis Pharma is spiraling upward by way of its TransCon platform. | Ascendis Pharma is spiraling upward by way of its TransCon platform. For the third time in six years, the Copenhagen-based ...
Quotient Sciences, a CDMO that specializes in "niche and smaller volume" drugs that it says are often overlooked by bigger contract manufacturers, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results